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Transcriptome analysis of 
extended-spectrum β-lactamase-
producing Escherichia coli and 
methicillin-resistant Staphylococcus 
aureus exposed to cefotaxime
P. R. Brochmann1, A. Hesketh2,3, B. Jana1, G. H. Brodersen1 & L. Guardabassi1
Previous studies on bacterial response to antibiotics mainly focused on susceptible strains. Here we 
characterized the transcriptional responses of distinct cephalosporin-resistant bacteria of public 
health relevance to cefotaxime (CTX), a cephalosporin widely used in clinical practice. Adaptation to 
therapeutic concentrations of CTX (30 µg/ml) was investigated by RNA sequencing in mid-exponential 
phase cultures of a methicillin-resistant Staphylococcus aureus (MRSA) and two genetically diverse 
E. coli producing CTX-M-15 or CMY-2 β-lactamase following genome sequencing and annotation for 
each strain. MRSA showed the most notable adaptive changes in the transcriptome after exposure to 
CTX, mainly associated with cell envelope functions. This reprogramming coincided with a transient 
reduction in cell growth, which also occurred in the CMY-2-producing E. coli but not in the CTX-M-15-
producing strain. Re-establishment of growth in the CMY-2 producer proceeded without any notable 
adaptive transcriptional response, while limited reprogramming of gene transcription was observed in 
the CTX-M-15 producer. Our data show that the transcriptional response of CTX-resistant bacteria to 
CTX depends on the bacterial species, level of resistance and resistance determinant involved. Gene 
products induced in the presence of CTX may play an essential role for bacterial survival during therapy 
and merit further investigation as possible targets for potentiating CTX.
Oxyimino-cephalosporins such as cefotaxime (CTX) are classified by the World Health Organization (WHO) 
amongst the “highest priority critically important antimicrobials” for human medicine1. They are safe and 
broad-spectrum β-lactam antibiotics that play a pivotal role in the management of infections caused by both 
Gram-negative and Gram-positive pathogens. Resistance to these agents is mediated by a variety of mechanisms 
depending on the specific microorganism involved. The most common mechanism in Escherichia coli and other 
Gram-negative pathogens is enzymatic drug degradation via production of extended-spectrum β-lactamases 
(ESBLs) belonging to different functional and structural classes2. ESBLs are mainly disseminated by horizontal 
transfer of plasmids across diverse E. coli lineages3, but also via dissemination of certain high-risk clones such 
as sequence type (ST) 131, which has significantly contributed to the global spread of CTX-M-15 and other 
ESBL types4. Among Gram-positive pathogens, Staphylococcus aureus and other staphylococci have developed a 
completely different mechanism of resistance that makes them clinically resistant to all conventional β-lactams, 
including oxyimino-cephalosporins. In this case resistance is encoded by a large mobile chromosomal element 
(staphylococcal cassette chromosome mec, SCCmec) that carries the methicillin resistance gene mecA encoding a 
penicillin binding protein (PBP2a) with low affinity for β-lactams5. Methicillin-resistant S. aureus (MRSA) spread 
by dissemination of epidemiologically successful clones, including the livestock-associated clone belonging to 
ST398, which can be transmitted to humans by direct contact with livestock or environmental exposure6.
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Previous studies have shown that bacterial responses to antibiotics include induction of both common and 
drug-specific changes in gene transcription7–9. Earlier studies on adaptation to antibiotics have focused on meas-
uring gene expression profiles of susceptible bacteria exposed to antibiotics at sub-MIC8. Here we analyze the 
responses of ESBL-producing E. coli and MRSA strains to CTX. The aim was to elucidate the transcriptomic 
response of different cephalosporin-resistant bacteria of public health relevance after exposure to a CTX concen-
tration mimicking antimicrobial therapy (30 µg/ml). Three well-characterized isolates were used as model strains: 
two E. coli strains producing CTX-M-15, a class A ESBL2 that is widespread among human clinical isolates10,11, 
and CMY-2, a class M ESBL2 that is common in both humans and animals12–14, respectively, and a MRSA strain 
belonging to the livestock-associated clone ST398. By using the selected strains, we gained insight into the stress 
responses of different types of bacteria exposed to the antibiotic they are resistant to. Bacterial cultures were 
exposed to CTX in mid-exponential phase and the transcriptome was profiled immediately before antibiotic 
exposure and 30 and 90 min after by RNA-sequencing. This approach included genome sequencing of all three 
strains in order to identify all genes putatively involved in CTX resistance and permit the subsequent analysis of 
the transcriptomes.
Results
Genetic potential for CTX resistance in the selected E. coli and S. aureus strains. Two ESBL-
producing E. coli strains UR40 (ST131) and R7AC (ST297), and MRSA 55488 (ST398) were used as models for 
this study. E. coli UR40 harbors blaCTX-M-15 on an IncF plasmid and originated from a human patient with urinary 
tract infection15 while E. coli R7AC carries blaCMY-2 on a IncI1 plasmid (pR7AC) and was isolated from dog fae-
ces16. MRSA 55488 harbors mecA on a SCCmec type Vc (5C2&5) and was isolated from a healthy pig farmer17. 
The three strains displayed the following MICs of CTX: >256 µg/ml (UR40), 16 µg/ml (R7AC) and 8 µg/ml 
(55488). The genome sequences for the two E. coli strains were determined and analysed alongside the sequence 
available for S. aureus 5584417 in order to obtain a complete picture of the genetic potential for CTX resistance in 
each strain. Table 1 lists the known genes conferring acquired clinical resistance to β-lactams. Additional genes 
putatively involved in β-lactam resistance, including regulatory genes, are listed in Supplementary File 1. The 
genome of E. coli R7AC contained two resistance genes coding for plasmid-mediated and chromosomal AmpC 
β-lactamase, blaCMY-2 (UG47_03805) and ampC (UG47_16890), respectively. The annotated sequences of the two 
genes are here the same. Thus, the gene names were assigned based on interpretations of expression results and 
knowledge from the literature about the genes.
Effects of CTX on strain growth and viability. Triplicate cultures of each strain were exposed in 
mid-exponential growth phase to the same therapeutic concentration of CTX (30 μg/ml) and sampled to deter-
mine the effects on growth, viability and expression of the transcriptome as described in the Materials and 
Methods. Markedly different effects of CTX on growth and viability were observed based on the resistance level 
in each strain (Fig. 1). While CTX-M-15-producing E. coli UR40 (MIC > 256 µg/ml) was completely unaffected 
by CTX compared to the unexposed culture, CMY-2-producing E. coli R7AC (MIC = 16 µg/ml) and the MRSA 
strain (MIC = 8 µg/ml) showed a temporary decrease in both culture optical density and viable counts in the 1 to 
6 hour period following CTX addition (Fig. 1a,b). The CMY-2-producing E. coli eventually recovered to approxi-
mately the levels seen in the unexposed controls, while the MRSA strain recovered to a lesser extent. The recovery 
process is likely to involve both adaptations in gene expression allowing improved survival and growth in the 
presence of CTX, and also stochastic heterogeneity in the bacterial cultures leading to the survival and eventual 
growth of sub-populations of more resistant cells. In the analysis of the changes in the transcriptome over the 
90 min period immediately following CTX addition described below, we focus on the first of these two processes.
Effects of CTX on expression of predicted β-lactam resistance genes. Analysis of the transcription 
of the genes directly involved in β-lactam resistance (Table 1) indicated very high and constitutive expression of 
blaCTX-M-15 (UG58_19655) in all samples of E. coli UR40 (Fig. 1c). This strain also exhibited significant constitutive 
expression of blaTEM-1 (UG58_26285) and blaOXA-1 (UG58_26550). Similarly, blaCMY-2 (UG47_03805) and blaTEM-1 
(UG47_05450) showed constitutively high levels of transcription in E. coli R7AC. The chromosomal ampC was 
poorly expressed in UR40 and not transcribed at all in R7AC. Uniquely, CTX up-regulated transcription of genes 
Strain Gene identifier Gene name
Protein 
name Link to β-lactam resistance Genbank accession
E. coli R7AC
UG47_03805 blaCMY-2 CMY-2 β-lactamase WP_001447737.1
UG47_16890 ampC AmpC β-lactamase WP_001447737.1
UG47_05450 blaTEM-1 TEM-1 β-lactamase WP_010331504.1
E. coli UR40
UG58_19655 blaCTX-M-15 CTX-M-15 β-lactamase WP_000239590.1
UG58_26285 blaTEM-1 TEM-1 β-lactamase WP_010331504.1
UG58_26550 blaOXA-1 OXA-1 β-lactamase WP_032491311.1
UG58_08585 ampC AmpC β-lactamase WP_001336292.1
MRSA 55488
WG79_13605 mecA PBP2a Low-affinity penicillin-binding protein WP_001801873.1
WG79_09935 blaZ BlaZ β-lactamase WP_002457930.1
Table 1. Known genes conferring acquired clinical resistance to β-lactams in the three strains under study.
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directly specifying β-lactam resistance only in the MRSA strain (Fig. 1c). Transcription of mecA (WG79_13605) 
and blaZ (WG79_09935) was induced 3.8 and 11.3-fold (Supplementary File 2), respectively, 30 min after treat-
ment. Transcription of the blaZ regulatory genes, blaR1 (WG79_09940) and blaI (WG79_09945), were also 
immediately induced in response to CTX, exhibiting a similar profile of induction to that observed for blaZ 
(Fig. 1c).
Effects of 30-min CTX exposure on the global transcriptional response. Principal components 
analysis (PCA) was used for unsupervised clustering of the RNA-sequencing data to produce an initial high-level 
comparison of the global transcriptional response to CTX occurring in each strain (Fig. 2a). By definition, the 
first principal component (PC1) explains the highest variability in the transcript abundance data being analyzed, 
while the second component (PC2) covers the second highest (etc). PCA can thus reveal global trends in the 
similarities and differences between the transcriptome data acquired for each sample. A clear separation in PC1 
of the CTX-treated sample replicates from the untreated controls was observed for the MRSA strain, indicating a 
more defined transcriptional response to CTX in this Gram-positive strain than in the two E. coli strains (Fig. 2b). 
This observation was especially evident for the samples taken 30 min after CTX addition (Fig. 2a), and was con-
sistent with CTX eliciting a more rapid transcriptional response in the S. aureus strain (Fig. 2b). The results from 
statistical testing supported this hypothesis (Supplementary Files 2–4). In MRSA 55488, 393 genes (~15% of the 
genome) showed significant [false discovery rate (FDR) ≤ 0.05 at a >1.5-fold change threshold] changes in tran-
script abundance in the CTX-exposed cultures relative to the control, while for E. coli UR40 and R7AC only 31 
and 34 significant transcripts were identified, respectively (<1% of each genome).
Effects of 90-min CTX exposure on the global transcriptional response. Consideration of the sam-
ples taken 90 min after addition of CTX in the PCA analysis confirmed the establishment of a CTX-dependent 
Figure 1. The effect of CTX (30 μg/ml) on (a) growth and (b) viability of CMY-2-producing E. coli R7AC, 
CTX-M-15-producing E. coli UR40 and MRSA 55488, and (c) its relationship to expression of genes putatively 
involved in CTX resistance (Supplementary File 1). For (a) and (b) addition of CTX to the cultures is arrowed 
(subsequently defined as 0 min), and the sampling points for the transcriptome analysis at 30 min and 90 min 
after antibiotic addition are indicated with dotted lines. The mean of log10 values from triplicate experiments 
(+/− standard deviation) are shown for (a) OD measurements at 600 nm, and (b) CFU from viability assays. 
The normalized log2(RPKM) mean abundance of transcripts (n = 3) putatively involved in CTX resistance 
in each strain for the 0, 30 and 90 min samples is shown in (c) (see Table 1 and Supplementary File 1). 
Constitutively high expression of UG58_19655 encoding CTX-M-15 is associated with the lack of sensitivity of 
strain UR40 towards CTX.
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transcriptional program in the MRSA strain. The MRSA adaptive response to CTX included a down-regulation 
of genes required for growth, and extensive changes in transcription associated with cell envelope functions. 
Exposure of the MRSA strain to CTX significantly altered the abundance of 734 unique transcripts in the 90 min 
period following addition of CTX, relative to the control cultures. Hierarchical clustering of the transcript 
abundance profiles grouped these into 7 different expression profiles, including three which show a marked 
down-regulation in expression in the CTX-exposed samples compared to the control (Fig. 3, Supplementary 
File 6; clusters 4, 5 and 6). The transcripts in cluster 6 encode proteins that are associated with translation 
(GO:0006412, p-value: 6.00E-20) and de novo inosine 5′-monophosphate (IMP) biosynthesis (GO:0006189, 
p-value: 3.28E-13). As both processes are required for cell growth, this result is consistent with the reduction in 
culture OD600 and viability observed after CTX addition (Fig. 1), indicating a programmed reduction in growth 
in response to the antibiotic challenge. The MRSA response also included a marked up-regulation of a large clus-
ter of genes (cluster 2 in Fig. 3) showing functional enrichment for branched chain amino acid biosynthesis and 
membrane components. This cluster also contained the majority of the general cell wall stress stimulon genes18,19 
and the β-lactamase locus WG79_09935-WG79_09945 (Supplementary File 6). Cluster 4 in Fig. 3 shows a signif-
icant coordinated down-regulation of genes encoding membrane components, which when considered alongside 
the results from cluster 2 indicated a complex reorganization of cell envelope functions in response to CTX. 
Interestingly, the data also indicate a shift away from using cytochrome c oxidase as the terminal electron accep-
tor in respiration following CTX treatment, towards using cytochrome d, suggesting a reduction in oxygen ten-
sion in the cultures arising from the CTX exposure (Fig. 3c). The small group of transcripts identified as being 
induced in abundance in response to CTX in cluster 7 shows functional enrichment for amino acid transport and 
programmed cell death, consistent with the induction of processes for recycling nutrients from cells terminally 
damaged by the antibiotic exposure.
The majority of the CTX-induced changes in CMY-2-producing E. coli R7AC were associated with fail-
ure to enter stationary phase, and not with the initiation of an adaptive response. For this strain, the 90-min 
Figure 2. The transcriptome of MRSA 55488 responds more dynamically to CTX treatment than either of the 
E. coli strains. (a) PCA analysis of normalized transcript abundances (principal component 1 (PC1) v principal 
component 2 (PC2)) characterizes the global transcriptional changes taking place in response to both time and 
CTX treatment. The percentages given in brackets correspond to the proportion of the variability in the data 
explained by PC1 or PC2. (b) The numbers of transcripts significantly changed in abundance over the 30 and 
90 min time periods following CTX exposure, relative to the unexposed control. Significance was determined 
using limma treat with an FDR ≤ 0.05 applied to a fold-change threshold of 1.5. Lists of differentially expressed 
transcripts are provided in Supplementary Files 2–4. The significantly differently expressed transcripts identified 
for 55488-ST398 include a marked and immediate up-regulation in transcription of the general cell wall stress 
stimulon (CWSS) previously identified by (c) McAleese et al.18 and (d) Bernal et al.19 (normalized log2(RPKM) 
mean abundance of transcripts are shown (n = 3) and plots have been mean centered). See Supplementary File 5 
for details of the stress stimulon genes in 55488-ST398.
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CTX-exposed samples are separated from all other samples by a combination of both PC1 and PC2, indicating 
a distinctive transcriptional profile. PC1 however primarily separated the 90-min control samples from the ear-
lier 30-min control time points, demonstrating a significant time-dependent component to the changes in tran-
scription occurring in these cultures. Differential expression analysis and transcript clustering were performed 
to characterize the difference between the behaviours of E. coli R7AC in the presence of CTX compared to the 
control condition (Fig. 4a, Supplementary File 7). Two large clusters of transcripts were identified which showed 
a marked increase (cluster 1) or decrease (cluster 2) in abundance in the control cultures that was absent (or much 
reduced) in the CTX-exposed cultures over the same 90 min period. The genes represented by cluster 2 are sig-
nificantly enriched for functions associated with translation, nitrogen metabolism and nucleoside biosynthesis, 
while cluster 1 is enriched for catabolic processes and for respiration (Fig. 4b). The abundance of a relatively small 
number of transcripts was found to specifically change in response to CTX, as represented by clusters 3 and 4 in 
Fig. 4. Interestingly, cluster 4, which showed up-regulation in response to CTX, is significantly enriched for genes 
encoding enzymes for de novo IMP biosynthesis, and thiamine biosynthesis.
Only a small number of transcripts (113/4888, 2%) showed significant changes in abundance between 
the control and CTX-exposed cultures of CTX-M-15-producing E. coli UR40 strain after 90 min (Fig. 2 and 
Supplementary File 4). Clustering and functional analysis provided evidence for a CTX-dependent transcrip-
tional response that involved expression of a number of genes with predicted functions related to sugar transport 
and metabolism, 12 genes encoding transcriptional regulators and two predicted stress inducible genes (Fig. 5c 
and Supplementary File 8). Three genes (UG58_01930, UG58_01935 and UG58_13625) encoding enzymes from 
the de novo IMP biosynthesis pathway were also notably down-regulated with respect to the control samples in 
the 90 min samples, although the remainder of the pathway was unaffected.
Discussion
We examined the response of different types of cephalosporin-resistant bacteria of high clinical relevance, namely 
ESBL-producing E. coli and MRSA, after exposure to a high concentration of CTX (30 μg/ml) that is achieved in 
serum after standard dosage. The inhibitory effects of CTX on growth of the CMY-2-producing E. coli and MRSA 
strains were expected since the CTX concentration used exceeded the MICs of CTX in the two strains (16 and 
Figure 3. The transcriptional response of MRSA 55488 to CTX includes a down-regulation of genes required 
for growth, and a marked reorganization of cell envelope associated functions. The transcripts (n = 734) 
identified as being differentially expressed in response to CTX were clustered (a) and gene ontology (GO) 
enrichment analysis was applied to each cluster (ct) for functional classification (b). Cluster 4 contains a putative 
operon of genes encoding a cytochrome c oxidase, whose transcription contrasts with the predicted cytochrome 
d oxidase genes identified in cluster 2 (c). Normalized log2(RPKM) mean abundance of transcripts are shown 
(n = 3), and the plots in (a) but not (c) have been mean centered. Where shown, error bars correspond to +/− 
SD (n = 3). Cluster membership is listed in Supplementary File 6, together with the complete gene ontology 
analysis results.
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8 µg/ml, respectively). The higher susceptibility of these two strains explains the significant changes in abundance 
of transcripts between control and CTX-exposed cultures (1454/4851 (30%) and 964/2587 (37%) respectively, 
Fig. 2b and Supplementary Files 2, 3). These transcripts belonged to various functional categories, which included 
catabolic, cellular respiration, fermentation, polyol catabolic, translation, nitrogen compound, metabolic, nucle-
oside biosynthetic, de novo IMP biosynthetic and thiamine biosynthetic processes for CMY-2-producing E. coli 
(Fig. 4 and Supplementary File 7); and lysine biosynthetic, membrane, branched-chain amino acid biosynthetic, 
urea catabolic, membrane part, electron carrier activity, proteolysis, translation, de novo IMP biosynthetic, pro-
grammed cell death, amino acid transport processes for MRSA (Fig. 3 and Supplementary File 6). Altogether, 
these data show a clear relationship between the CTX resistance phenotype and transcriptional response of resist-
ant bacteria to CTX. However, the response of each strain was unique, suggesting that factors other than the 
MIC are responsible for modulating the transcriptional response, such as the nature of the bacterial cell wall 
(Gram-positive vs Gram-negative), the type of resistance mechanism (acquisition of a low-affinity target vs enzy-
matic degradation) and the activity of the specific β-lactamase involved (BlaZ vs CMY-2 vs CTX-M-15).
The MRSA transcriptome responded more rapidly and dynamically to CTX than the two E. coli strains. The 
significant changes in MRSA gene expression included all of the cell wall stress stimulon genes initially identi-
fied by McAleese et al.18, and 44/58 of those in the extended stimulon subsequently proposed by Bernal et al.19 
(Fig. 2c,d). The stimulon corresponds to a group of genes induced in S. aureus following exposure to a variety 
of cell wall active antibiotics, including vancomycin, oxacillin, bacitracin and daptomycin. Activation of the cell 
wall stress stimulon by CTX is consistent with a rapid CTX-dependent alteration in the transcriptional program 
of MRSA that is apparently absent in the E. coli strains. CTX did not significantly affect transcription of the 
‘accessory gene regulator’ operon agrBDCA (WG79_09750 - WG79_09735), but a general decrease in transcript 
abundance was observable following CTX addition (Supplementary Fig. 1). The agr gene regulatory system is 
important for pathogenicity and virulence in MRSA20 and a recent study found evidence for a trade-off between 
virulence regulation by agr and the regulation of β-lactam antibiotic resistance whereby transcription of the agr 
operon was repressed in the presence of nafcillin21. This was attributed to the presence of a potential MecI/BlaI 
operator binding site overlapping the agr operator sites in the agrB promoter and it is interesting to note that the 
strain used in this study shares the same sequence arrangement (Supplementary Fig. 1).
Figure 4. CTX-dependent changes in transcription in CMY-2-producing E. coli R7AC are associated with 
failure to enter transition phase in the 90 min period following CTX addition. The transcripts (n = 1454) 
identified as being differentially expressed between the control and CTX-exposed cultures were clustered (a) 
and gene ontology (GO) enrichment analysis was applied to each cluster (ct) for functional classification (b) 
Plots to contrast the transcript abundance measurements for the significant genes in R7AC-ST297 ct 2 that 
are present in the translation GO category, and R7AC-ST297 ct 1 in the cellular respiration category, with 
orthologues in strain UR40-ST131 are shown in (c). Normalized log2(RPKM) mean abundance of transcripts 
are shown (n = 3), and all the plots have been mean centered. Cluster membership is listed in Supplementary 
File 7, together with the complete gene ontology analysis results.
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CTX treatment induced only limited changes in the transcriptome of E. coli UR40 (Fig. 2). This is consist-
ent with high-level constitutive expression of CTX-M-15 β-lactamase in this strain which apparently helps to 
provide complete protection against CTX at the phenotypic level (Fig. 1). Constitutive expression of blaTEM-1 
(UG58_26285) and blaOXA-1 (UG58_26550), but not ampC (UG58_08585), likely also contributes to this pro-
tection (Fig. 1). Evidence for CTX-induced adaptations in internal cell physiology was however obtained, with 
changes in sugar transport and metabolism, IMP biosynthesis, and gene regulation identified as part of the 
response to CTX (Fig. 5 and Supplementary File 8). We hypothesize that these adaptations may be important for 
surviving the effects of the antibiotic even in strains expressing high-levels of CTX resistance (MIC > 256 µg/ml).
Constitutive expression of the β-lactamase resistance genes blaCMY-2 (UG47 03805) and blaTEM-1 (UG47_05450) 
was insufficient to provide the R7AC strain with the level of protection from CTX that was observed in the 
UR40 strain (Fig. 1). Specific reprogramming of gene expression in response to CTX in strain R7AC was also 
limited. The majority of transcripts changing significantly in abundance between the control and CTX-treated 
cultures correspond to changes expected on entry into transition phase (eg. down-regulation of transcription 
of genes encoding the translational apparatus) taking place in the control cultures over the 90 min period of the 
experiment, but not occurring in the CTX-treated cultures. This suggests an arrest of growth following CTX 
treatment that is not dependent on the stringent control of translation. Significant changes in transcription of 
genes required for IMP biosynthesis were however again observed and this is discussed in more detail below. E. 
coli, like S. aureus, has regulatory systems to respond to cell envelope and other stresses. Miller et al. reported an 
SOS cell division inhibition response induced via the dpiAB two-component regulatory system by exposure of a 
Figure 5. Limited effects on CTX-M-15-producing E. coli UR40 transcription in response to CTX. The 
transcripts (n = 113) identified as being differentially expressed in response to CTX were clustered (a) and GO 
enrichment analysis was applied to each cluster for functional classification (b). The mean of the log2(RPKM) 
normalized transcript abundances are shown (n = 3), and all plots have been mean centered. Transcription of 
genes highlighted by the GO analysis, or from selected genes of interest present in cluster 1, are shown (c). Error 
bars correspond to +/− SD (n = 3). Cluster membership is listed in Supplementary File 8, together with the 
complete gene ontology analysis results.
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susceptible E. coli strain UT481 to sub-lethal concentrations of ampicillin22. Jozefczuk et al. also characterized a 
general stress response in E. coli which includes common changes in expression of the transcriptome in response 
to cold shock, heat shock, oxidative stress, lactose diauxie and entry into stationary phase23. CTX treatment of the 
E. coli strains used in this study interestingly did not reproduce either of these responses. This is consistent with 
a previous study analyzing CTX-induced stress in a CTX-M-1-producing E. coli MG1655 genetic background24.
The transcription of genes involved in de novo IMP biosynthesis showed notable strain-to-strain variability 
both in the changes in expression with time and in response to CTX treatment, despite growth in the same culture 
medium (Supplementary Fig. 2). This pathway was also reportedly significantly up-regulated following treatment 
of E. coli MG1655 strains expressing CTX-M-1 β-lactamase resistance with sub-inhibitory concentrations of 
CTX24. Purine nucleotide biosynthesis is required for cell growth and proliferation, supplying precursors for the 
synthesis of DNA and RNA, and for ATP and GTP biosynthesis for cellular energy metabolism. In E. coli UR40 
the genes involved in IMP biosynthesis were induced equally in both the CTX-treated and control cultures as 
the cultures aged, consistent with a gradual depletion of purines from the medium and an increased demand for 
de novo synthesis. In contrast, the significant increase in transcription of genes required for IMP biosynthesis 
90 min after CTX exposure in E. coli R7AC, and in the previous report of CTX-M-1-producing E. coli MG1655 
treated with CTX24, may reflect the increased need for nucleotide precursors for overcoming CTX stress and 
resuming growth in these strains. The reason for the increased demand for purine nucleotides following CTX 
treatment is unknown but it may at least in part be attributable to perturbations in energy use or increases in 
DNA repair mechanisms. Exposure of E. coli to bactericidal antibiotics such as CTX is known to increase rates 
of respiration25 and induce reactive oxygen species (ROS) leading to DNA damage26,27. A recent metabolomics 
study of E. coli exposed to a lethal concentration of bactericidal antibiotics showed a decrease in the abundance 
of nucleotide precursors within cells which was attributed to an increase in nucleotide turnover arising from 
DNA damage27,28. β-lactam antibiotics have also been shown to induce a toxic malfunctioning of peptidoglycan 
biosynthesis in E. coli, causing a futile cycle of cell wall synthesis and degradation and thereby depleting cellular 
energy resources and promoting cell death29. In contrast to E. coli, CTX-dependent induction of IMP biosynthetic 
genes was not observed in S. aureus 55844 in the present study. Indeed, genes required for the IMP pathway were 
significantly down-regulated both 30 and 90 min after exposure to CTX in this strain. While this may reflect an 
increase in purine nucleotide availability due to cell lysis, or a reduced demand for purine nucleotides in the 
growth-inhibited cultures, it can be argued that these conditions apply equally well to the E. coli R7AC cultures 
where the opposite effect on IMP biosynthesis gene expression was observed during growth in the same medium 
(Supplementary Fig. 2). The contrasting effects in the two species are intriguing but the underlying mechanism 
is yet to be determined.
Some of the genes for which expression was significantly altered during antibiotic exposure may be required 
to support the resistance phenotype and could be used as targets to develop ‘helper’ drugs that potentiate CTX 
activity30. The only example of antibiotic helper drugs in clinical practices are β-lactamase inhibitors. While these 
agents potentiate β-lactams only against resistant strains, the helper drugs conceptualized in our research would 
also potentiate antibiotic activity against susceptible strains, contributing to reduce the risk of treatment failure 
due to extrinsic non-bacterial factors. Given the strain-specific transcriptomic responses observed in our study, 
development of universal helper drugs that potentiate CTX against both MRSA and ESBL-producing E. coli 
may be challenging. Various histidine kinases and their associated sensor proteins were upregulated following 
exposure of the three strains to CTX (e.g. the histidine kinase VraS (WG79_11075) in MRSA, atoS and uhpB in 
E. coli). These sensory systems are attractive novel antibacterial targets due to their universal involvement in the 
regulation of bacterial stress responses31 and for the same reason can be regarded as promising antimicrobial 
helper drug targets. Putative histidine kinase inhibitors targeting the autophosphorylation domain of the protein 
have shown antibacterial effect across different bacterial species32.
Some of the processes influenced by CTX exposure (e.g. up-regulation of certain amino acid biosynthesis 
pathways or switching on of the cell wall stress stimulon in MRSA, and upregulation of sugar transport and 
metabolism in E. coli UR40) could be targeted to potentiate CTX activity against one of the two bacterial species. 
Among possible species-specific helper drug targets revealed by this study, VraX and PrsA are possible targets 
for CTX potentiation against MRSA since these proteins were significantly overexpressed (9.83 and 4.3 logFC, 
respectively) upon exposure of the MRSA strain to CTX. Overexpression of VraX was previously reported in 
S. aureus challenged by another antibiotic that targets the cell wall, vancomycin18. A recent study by Yan et al. 
supports the hypothesis that VraX overexpression may be a protective response for S. aureus survival and the 
protein may be involved in pathogenesis by inhibiting the classical pathway of the complement system33. PrsA 
is a peptidylprolyl isomerase that presumably plays a role in the post-translational maturation of PBP2a34 and 
is involved in the maturation of the S. aureus secreted virulence factor nuclease (Nuc)35. Therefore, both VraX 
and PrsA are promising targets to modulate both antimicrobial resistance and pathogenesis in this bacterial 
species. Cytochrome d similarly represents a potentially attractive target. A significant up-regulation in tran-
scription of genes encoding subunits of this cytochrome in response to CTX (Fig. 3), concomitant with a marked 
down-regulation in expression of genes encoding the principle cytochrome c, suggest an important role for the 
regulation of cytochrome composition in adapting to the presence of the antibiotic. The cytochrome d family is 
unique to prokaryotes where it performs respiratory functions under microaerobic conditions and has previously 
been suggested as a general drug target for the treatment of bacterial pathogens36. Amongst the possible CTX 
helper drug targets in E. coli, GuaB was highly overexpressed in R7AC (4.83 log FC), and could be a candidate 
to potentiate CTX against β-lactamase-producing strains that display moderate levels of resistance such as this 
strain (MIC = 16 µg/ml). This inosine-5′-monophosphate dehydrogenase (IMPDH) plays an important role in 
the regulation of cell growth by catalyzing the conversion of inosine 5′-phosphate to xanthosine 5′-phosphate, 
the first step of guanosine 5′-monophosphate biosynthesis37. Even though IMPDHs are non-essential enzymes 
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in bacteria, their inactivation affects growth and virulence in several bacterial species38 and diphenyl urea-based 
IMPDH inhibitors have been shown to have potent anti-mycobacterial activity39.
This study describes and explores the immediate transcriptional changes occurring in response to CTX in a 
diverse group of CTX-resistant pathogens, and provides a valuable set of data to help guide the search for weak-
nesses in bacterial defences against antimicrobial therapies. Future research is warranted to investigate whether 
neutralization of the presumptive helper drug target proteins identified by this study, for example by deletion of 
the target-encoding gene, results in significant reductions of the MIC of CTX. Specific screening assays could be 
designed to identify compounds interfering with the most promising targets.
Materials and Methods
Bacterial strains. The following CTX resistant strains previously isolated from environments relevant to 
public health were selected for use in the study: the ESBL-producing E. coli strains UR40 (ST131)15 and R7AC 
(ST297)16 and the methicillin-resistant S. aureus 55488 (ST398)17.
Genome sequencing. For the two E. coli strains, genomic DNA was extracted for sequencing using the 
MasterPure™ DNA Purification Kit (Epicentre) according to the manufacturer’s instructions (with the excep-
tion of adding 3 μl (instead of 1 μl) of Ready-Lyse Lysozyme to each resuspended pellet (from 1.0 ml culture) 
of bacteria). De novo whole genome sequencing libraries were then created using the Nextera XT DNA Library 
Preparation Kit (Illumina), and the libraries sequenced using a 250-bp paired-end reads module on the Illumina 
MiSeq platform. MRSA 55488 was previously sequenced by Price et al.17, also using an Illumina platform (101-bp 
paired-end sequencing, Genome Analyzer IIx (GAIIx)). The average depth of sequencing coverage was 38 for 
strain UR40, 67 for R7AC, and 73 for 55488. The genomic assembly algorithm SPAdes was used to assemble 
the reference genomes from the sequencing reads, yielding 107 and 167 contigs for strains UR40 and R7AC, 
respectively. This compares to 45 contigs previously obtained for 5548817. For E. coli R7AC, assembled contigs 
that aligned to plasmid pR7AC using MUMmer were replaced with the complete plasmid sequence deposited at 
the National Center for Biotechnology Information (NCBI) under accession number KF434766.1. Each reference 
genome was annotated using the Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP) developed 
by NCBI. ResFinder V2.140 was used to identify acquired antimicrobial resistance genes. The identification was 
extended by a systematic manual search using the following keywords: mecA, methicillin, cefotaxime, cephalo-
sporin, lactam, bla, amp, metallo and penicillin to identify genes putatively involved in CTX resistance.
Growth and CTX treatment of bacterial cultures. The experiment was designed to assess the effects of 
therapeutic concentrations of CTX on mid-exponential phase cultures of the three model strains. It was estimated 
that a serum concentration of 30 µg/ml is achieved after 1 h following parenteral administration of 2 g of CTX to 
a 70 Kg person. This concentration was determined by using the pharmacokinetic-pharmacodynamic (PK-PD) 
mono-exponential equation known as the compartment model: C = C0 ∙ e−k ∙ t 41,42, where C is the calculated ther-
apeutic concentration, C0 is the initial plasma concentration, e is the exponential factor, k is the elimination rate 
constant and t is the time at which the therapeutic concentration is found in serum. C0 was calculated from the 
dose distribution (Dose) divided by the volume of distribution (VD): C0 = Dose/VD.
Triplicate cultures of each strain in cation-adjusted Müller-Hinton broth CAMHB (Sigma-Aldrich) were 
incubated at 37 °C under shaking (180 rpm) until reaching mid-exponential phase (OD600 = 0.1, 107 CFU/ml), 
approximately after 2 h and 40 min for E. coli and after 3.5 h for S. aureus. At this stage, each culture replicate was 
divided into two 3 L flasks containing 250 ml. One was treated with 30 µg/ml of CTX, while the second was used 
as a control. All cultures were further incubated as described above, and sampled every hour for optical density 
measurements and cell counts. Samples for RNA extraction were taken immediately before treatment, and 30 and 
90 min after.
RNA extraction and sequencing. Culture samples were harvested directly into double the volume 
of RNAprotect Bacteria Reagent (QIAGEN), incubated for 5 minutes, and then centrifuged. Cell pellets were 
stored at −20 °C before RNA extraction on the following day. Total RNA was isolated using RNeasy Mini col-
umns (QIAGEN) with a modification to the manufacturer’s instructions. Briefly, cells were lysed in the presence 
of 300 mg acid-washed glass beads (150–600 μm diameter, Sigma) using a Fast Prep Lyser (Eppendorf) with 
three cycles of 1 min at maximum speed and one cycle of 7 min, cooling the samples on ice for 2 min before and 
between cycles. On-column DNA digestion was performed using the RNase-Free DNase Set kit (QIAGEN). RNA 
sample integrity was verified using a NanoDropTM, (absorbance ratios 260/280 nm and 260/230 nm ≥1.8) and a 
Bioanalyzer 2100 (RNA Integrity Number (RIN) ≥7). Samples of total RNA (≥5 μg, measured on a Qubit) were 
submitted to a commercial provider (Beijing Genomics Institute) for transcriptome sequencing. Prior to sequenc-
ing, all samples were treated with DNaseI (New England Biolabs® Inc) and then enriched for mRNA molecules 
via ribosome-depletion using the Ribo-Zero™ magnetic Kit for bacteria (Epicentre). Sequencing was performed 
using an Illumina HiSeq 2000 with TruSeq V3 sequencing kits.
Transcriptome analysis. Sequencing reads (>10 million paired-end 90 bp reads per sample) were mapped 
to the genome sequences using tophat v2.0.1443 employing the default settings but with splice awareness turned 
off. Mapped reads were processed and analysed in R44. The transcriptome analyses are based on the annota-
tions available for these genomes on 05 July 2015. Reads mapping to annotated genome features were counted 
using Rsubread45, disallowing duplicate reads and reads that map to more than one location. Reads overlapping 
adjacent genes were counted for each gene. Transcripts exhibiting generally low counts were filtered out from 
the downstream analysis, retaining only those with >0.5 counts per million (cpm) in at least 3 of the samples. 
Transcript counts were TMM normalized and tested for differential expression using the limma voom method46,47 
with limma treat48. PCA was performed using pcaMethods49, and gene ontology (GO) analysis was performed 
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using GoSeq50. To identify sets of differentially expressed transcripts between CTX-exposed and control samples 
within each strain, the null hypothesis that the change in transcript abundance relative to the time at CTX addi-
tion (0 min) was equal in each control and CTX-exposed pair of samples was assumed according to Equation (1):
− − − =
− − − =
[(CTX exposed T30 T0) (Control T30 T0) 0]
and [(CTX exposed T90 T0) (Control T90 T0) 0] (1)
A limma treat transcript fold-change threshold of 1.5 was used. For each strain, the significant (p ≤ 0.05) tran-
scripts identified from the T30 and T90 comparisons were combined to produce a universal list of transcripts 
significantly changing in abundance in the 90 min period following CTX addition. The abundance profiles of 
significant transcripts were hierarchically clustered (Pearson correlation, using complete linkage), and the clus-
ters subjected to GO analysis. For the GO analysis, the ontology annotations available for E. coli MG1655 and S. 
aureus NCTC8325 (as available from the European Bioinformatic Institute on 14 November 2016) were mapped 
onto the orthologues present in the strains used in this study. Orthologue identification was performed at the 
protein level by reciprocal best hit BLAST analysis, requiring >90% amino acid identity over >50% of the length 
of the protein.
Nucleotide sequence accession numbers. The reference genome sequences are available at NCBI under 
the accession numbers: LAWT00000000, LAZA00000000 and LAWV00000000. The RNA-sequencing reads are 
available in the Short Read Archive (SRA) at NCBI under the accession numbers: SRX3171181 to SRX3171225.
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